Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc.

APRE
Aprea Therapeutics, Inc.US flagNASDAQ Global Select
0.76
USD
+0.00
- -
4.95MMarket Cap

Income Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
16
16
30
53
37
37
15
14
13
+ Selling, General & Admin
2
2
9
15
14
21
8
6
6
+ Research & Development
13
14
21
38
24
16
8
9
7
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
-1
-2
- -
Operating Income (Loss)
-16
-16
-30
-53
-37
-37
-15
-14
-13
- Non-Operating (Income) Loss
-1
-1
-1
1
- -
75
-1
-1
-1
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
-1
-1
-1
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
1
1
1
+ Other Non-Op (Income) Loss
-1
-1
-1
1
- -
76
- -
- -
- -
Pretax Income
-15
-16
-28
-53
-37
-113
-14
-13
-13
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-15
-16
-28
-53
-37
-113
-14
-13
-13
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-15
-16
-28
-53
-37
-113
-14
-13
-13
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-15
-16
-28
-53
-37
-113
-14
-13
-13
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-15
-16
-28
-53
-37
-113
-14
-13
-13
EBIT
-16
-16
-30
-53
-37
-37
-15
-14
-13
EBITDA
-16
-16
-29
-53
-37
-37
-15
-14
-13
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-16
-16
-30
-53
-37
-37
-15
-14
-13
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
1
1
- -
1
1
2
4
6
- -
Basic EPS, GAAP
-21.58
-22.06
-93.49
-50.61
-34.88
-67.99
-3.95
-2.35
- -
Basic EPS from Cont Ops
-21.58
-22.06
-93.49
-50.61
-34.88
-67.99
-3.95
-2.35
- -
Diluted Weighted Avg Shares
1
1
- -
1
1
2
4
6
- -
Diluted EPS, GAAP
-21.58
-22.06
-93.49
-50.61
-34.88
-67.99
-3.95
-2.35
- -
Diluted EPS from Cont Ops
-21.58
-22.06
-93.49
-50.61
-34.88
-67.99
-3.95
-2.35
- -

Balance Sheet (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
25
66
133
92
57
30
23
24
16
+ Cash, Cash Equivalents & STI
24
66
130
89
53
29
22
23
15
+ Cash & Cash Equivalents
24
66
130
89
53
29
22
23
15
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
3
3
4
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
1
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
25
66
134
93
57
30
23
24
16
+ Payables & Accruals
4
4
8
14
6
2
3
3
2
+ Accounts Payable
2
2
2
5
2
1
2
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
3
6
9
4
1
1
2
1
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
1
1
2
1
1
2
- -
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
1
2
1
1
1
- -
1
Total Current Liabilities
4
5
9
15
7
3
4
3
3
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
56
113
- -
- -
- -
1
1
1
1
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
56
113
- -
- -
- -
1
1
1
1
Total Noncurrent Liabilities
56
113
- -
- -
- -
1
1
1
1
Total Liabilities
61
117
9
15
7
5
6
5
3
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
19
20
226
231
241
330
336
351
357
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
19
20
226
231
241
330
336
351
357
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-47
-62
-91
-144
-181
-294
-308
-321
-334
+ Other Equity
-8
-9
-12
-10
-10
-11
-11
-11
-11
Equity Before Minority Interest
-36
-51
124
77
50
26
17
19
12
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-36
-51
124
77
50
26
17
19
12
Total Liabilities & Equity
25
66
134
93
57
30
23
24
16
Shares Outstanding
1
1
1
1
1
3
4
5
8
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
- -
- -
- -
- -
- -
- -
Net Debt
-24
-66
-130
-89
-53
-29
-22
-23
-15
Net Debt to Equity
68.23
127.68
-104.7
-115.02
-107.21
-112.26
-127.45
-118.35
-117.34
Tangible Common Equity Ratio
-144.44
-77.91
92.99
83.4
87.12
85.04
74.85
80.52
78.09
Current Ratio
5.75
13.56
14.68
6.03
7.73
9.42
5.14
7.01
5.63
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-15
-16
-28
-53
-37
-113
-14
-13
-13
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
-1
- -
6
7
89
- -
- -
1
+ Stock-Based Compensation
- -
- -
1
5
8
17
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-1
-1
-1
1
- -
72
- -
- -
- -
+ Chg in Non-Cash Work Cap
1
1
1
6
-8
-2
2
-1
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-3
- -
- -
2
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
1
4
6
-8
-4
1
- -
-1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-14
-15
-27
-42
-38
-25
-12
-14
-13
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
87
- -
2
1
6
16
5
+ Increase in Capital Stock
- -
- -
87
- -
2
1
6
16
5
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
23
56
6
- -
- -
- -
-1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
23
56
93
- -
2
1
5
15
5
Effect of Foreign Exchange Rates
1
- -
-1
1
- -
- -
- -
- -
- -
Net Changes in Cash
9
41
66
-42
-36
-24
-7
1
-8
EBITDA
-16
-16
-29
-53
-37
-37
-15
-14
-13
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-14
-15
-27
-42
-38
-25
-12
-14
-13
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-15
-27
-42
-38
-25
-12
-14
-13
Free Cash Flow per Basic Share
-19.9
-21.67
-89.1
-39.58
-35.41
-15.09
-3.39
-2.46
- -
Price/Free Cash Flow
- -
- -
-10.33
-2.49
-1.62
-0.44
-1.41
-1.34
- -
Cash Flow to Net Income
0.92
0.98
0.95
0.78
1.02
0.22
0.85
1.05
1.02
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -